ARCHIVES

Study of Dlurectic Use As Renal Cell Cancer Risk Gets Concept Approval

This article is from The Cancer Letter archive.

Vol. 15 No. 11 | March 10, 1989

Download PDF Visit The Full Archive

Related Articles

Antigenics Begins Phase II Trial Of Oncophage for NHL.

March 31, 2000

Denosumab Demonstrates Superiority Over Zometa For Bone Metastases

August 28, 2009

Scientific Opportunity Should Guide Fund Allocation, House Says

August 4, 1995

NCI SBIR Offers $10 million in 10 Awards

February 18, 2011

MRI Effective For Women With BRCA Gene Mutations

September 24, 2004

NCCS Networker Volume 5 Issue 3, Summer 1991

June 13, 1991